08048035968
Viropil Good Quality Tablet to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Viropil is a fixed-dose combination of three antiretroviral medicines. The combination belongs to two major antiretroviral classes: dolutegravir, an integrase strand transfer inhibitor (INSTI), and lamivudine plus tenofovir disoproxil fumarate, which are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).

The combination works at different stages of HIV replication and is used to reduce the amount of HIV in the blood and maintain viral suppression when taken consistently as prescribed. Current U.S. HIV treatment guidance recognizes dolutegravir combined with TDF and lamivudine as an effective initial antiretroviral regimen for many people with HIV.

Important: Viropil is a prescription medicine and should be used under the supervision of a qualified healthcare professional.

2. Product Information

Product DetailInformation
Brand NameViropil Tablet
Dosage FormTablet
Active IngredientsDolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg
Therapeutic ClassAntiretroviral
Drug ClassesINSTI + NRTIs
Manufacturer/MarketerEmcure Pharmaceuticals Ltd.
Typical Pack30 tablets
RouteOral
StorageStore below 30°C, according to product information
Prescription StatusPrescription medicine

The composition and 30-tablet presentation are documented by Indian medicine references.

3. Uses of Viropil

Viropil is primarily used for the treatment and management of HIV-1 infection as part of combination antiretroviral therapy.

Its objectives include:

  • Suppressing HIV replication.
  • Reducing HIV viral load.
  • Helping maintain or improve immune function.
  • Reducing the risk of HIV-related complications.
  • Helping maintain long-term viral suppression when taken consistently.

The specific ART regimen should be selected according to the patient's clinical condition, resistance testing, other medicines, kidney/liver function and other relevant factors.

4. Benefits of Viropil

When appropriately prescribed and taken consistently, Viropil can provide several treatment advantages:

  • Three active antiretroviral medicines in one tablet, simplifying the treatment regimen.
  • Helps suppress HIV replication.
  • Can contribute to sustained viral-load control.
  • May reduce the risk of HIV-related illness when effective viral suppression is achieved.
  • Once-daily fixed-dose treatment can simplify adherence.

The Indian National AIDS Control Organisation (NACO) describes the TDF + 3TC + DTG fixed-dose combination as a once-daily regimen and notes its advantages in simplifying treatment and delivery.

Note: Antiretroviral medicines control HIV; they do not currently cure HIV.

5. Side Effects of Viropil

Possible adverse effects can vary between individuals. Reported effects associated with the components of this combination may include:

  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Tiredness or weakness
  • Difficulty sleeping
  • Abdominal discomfort
  • Muscle pain or weakness
  • Rash

Most mild effects may improve as the body adjusts, but persistent or troublesome symptoms should be discussed with a healthcare professional.

Serious reactions are uncommon but can occur. Because tenofovir disoproxil fumarate can affect kidney function and bone health in some patients, appropriate clinical monitoring may be required.

6. Common Side Effects

Some commonly reported effects associated with antiretroviral treatment containing these medicines include:

  1. Headache
  2. Nausea
  3. Diarrhea
  4. Fatigue
  5. Dizziness
  6. Sleep disturbance
  7. Abdominal discomfort
  8. Muscle weakness or aches

If side effects are severe, persistent, or unusual, the patient should contact their healthcare provider rather than stopping treatment independently.

7. How to Use Viropil

Viropil should be taken exactly as prescribed by the doctor.

For the TDF/3TC/DTG fixed-dose combination, NACO guidance describes a once-daily regimen at a consistent time each day.

General administration guidance:

  • Swallow the tablet with water.
  • Take it at approximately the same time each day.
  • It may generally be taken with or without food unless your healthcare professional gives different instructions.
  • Do not change the dose yourself.
  • Do not stop ART suddenly without medical advice.
  • If a dose is missed, follow your doctor's or pharmacist's instructions rather than taking an extra dose.

The exact regimen may differ depending on the patient's HIV treatment history, resistance profile, kidney function, other medicines and clinical circumstances.

8. How Viropil Works

Viropil contains three medicines that act against HIV in different ways:

Dolutegravir

Dolutegravir is an integrase strand transfer inhibitor (INSTI). It blocks HIV integrase, an enzyme HIV needs to integrate its genetic material into human cells. This interferes with viral replication.

Lamivudine

Lamivudine is an NRTI. It interferes with HIV reverse transcriptase, an enzyme required for converting viral RNA into DNA.

Tenofovir Disoproxil Fumarate

Tenofovir is converted into an active form that also interferes with HIV reverse transcriptase, helping prevent production of new viral DNA.

Using medicines that act at different stages of HIV replication provides combination antiretroviral activity.

9. Safety Advice

Before starting Viropil, patients should inform their healthcare provider about:

  • Kidney disease or reduced kidney function.
  • Liver disease.
  • Hepatitis B infection.
  • Previous HIV treatment or antiretroviral resistance.
  • Pregnancy or plans to become pregnant.
  • Breastfeeding.
  • All prescription, OTC and herbal medicines being taken.
  • Any previous allergy to dolutegravir, lamivudine or tenofovir.

Important safety points:

  • Do not stop HIV treatment without medical advice because interruption can lead to viral rebound and potentially resistance.
  • Kidney function may need to be monitored during treatment.
  • Patients with HIV/HBV coinfection require particular care because stopping medicines active against HBV can cause hepatitis B to flare.
  • Drug interactions should be checked before taking other medicines, supplements or antacids.
  • Keep all scheduled viral-load, CD4, kidney and other recommended laboratory monitoring appointments.
  • Use only genuine medicines obtained through legitimate, authorized pharmaceutical channels.

10. Frequently Asked Questions

Q1. What is Viropil Tablet used for?

Viropil is an antiretroviral combination used for the treatment and management of HIV infection.

Q2. What does Viropil contain?

Each tablet contains Dolutegravir 50 mg, Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg.

Q3. Is Viropil an antibiotic?

No. Viropil is an antiretroviral medicine, not an antibiotic.

Q4. Can Viropil cure HIV?

No. Antiretroviral therapy suppresses HIV replication and can help people maintain long-term viral suppression, but it does not eradicate HIV from the body.

Q5. How often is Viropil taken?

The TDF/3TC/DTG combination is commonly administered once daily, but patients should follow the dosing instructions provided by their healthcare professional.

Q6. Can Viropil be stopped when the patient feels better?

No. HIV treatment should not be stopped without medical supervision.

Q7. Can Viropil be substituted with another HIV medicine?

Potentially, but substitution should be made by a qualified healthcare professional after considering the exact composition, HIV resistance profile, kidney/liver function, interactions and treatment history.

Q8. Does Viropil require a prescription?

Yes. Viropil is listed as a prescription medicine.

Q9. What should I do if I miss a dose?

Follow your healthcare provider's instructions. Do not routinely double the next dose to compensate for a missed dose.

Q10. Can Viropil interact with other medicines?

Yes. Antiretroviral medicines can interact with other medicines and supplements. Always provide your healthcare provider with a complete list of medicines you take.

11. Substitute for Viropil

A substitute should not be selected solely because the brand name or tablet strength appears similar. The substitute should contain an appropriate antiretroviral regimen determined by a healthcare professional.

For the same Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg combination, other brands/generic presentations may exist in different markets. The exact availability and regulatory status varies by country. The combination itself is recognized as DTG/3TC/TDF (TLD).

Examples of alternative HIV regimens include combinations containing dolutegravir with tenofovir and either lamivudine or emtricitabine, or other guideline-recommended ART combinations. These are not automatically interchangeable with Viropil and require medical assessment.

12. SEO Keywords for Phoenix Exim

Primary Keywords

  • Viropil Tablet exporter from India
  • Viropil Tablet supplier from India
  • Viropil Tablet pharmaceutical exporter
  • Viropil Tablet wholesale supplier
  • Viropil Tablet export from Nagpur India
  • Viropil 50mg 300mg 300mg Tablet
  • Dolutegravir Lamivudine Tenofovir Tablet exporter
  • Dolutegravir 50mg Lamivudine 300mg Tenofovir 300mg supplier
  • TLD HIV medicine exporter India
  • HIV antiretroviral medicine exporter India

Long-Tail B2B Keywords

  • Buy Viropil Tablet from pharmaceutical exporter in India
  • Viropil Tablet bulk supplier from Nagpur India
  • Viropil Tablet international pharmaceutical supplier
  • Viropil Dolutegravir Lamivudine Tenofovir exporter India
  • Viropil Tablet wholesale pharmaceutical supplier India
  • Viropil Tablet for international medicine supply
  • Dolutegravir Lamivudine Tenofovir TLD exporter from India
  • TLD antiretroviral tablets wholesale supplier India
  • HIV treatment medicines pharmaceutical exporter from India
  • Quality Viropil Tablet supplier for international buyers
  • Viropil Tablet supplier to USA
  • Viropil Tablet supplier to UK
  • Viropil Tablet supplier to Australia
  • Viropil Tablet supplier to Singapore
  • Viropil Tablet supplier to Canada
  • Viropil Tablet supplier to South Korea
  • Viropil Tablet supplier to UAE
  • HIV medicines exporter from Nagpur India
  • Antiretroviral medicine exporter from Nagpur India
  • Pharmaceutical medicine exporter Nagpur India

SEO Location Keywords

  • Viropil Tablet exporter Nagpur India to USA
  • Viropil Tablet exporter Nagpur India to UK
  • Viropil Tablet exporter Nagpur India to Australia
  • Viropil Tablet exporter Nagpur India to Singapore
  • Viropil Tablet exporter Nagpur India to Canada
  • Viropil Tablet exporter Nagpur India to South Korea
  • Viropil Tablet exporter Nagpur India to UAE
Aug 13th, 2026 3:29 PM

Keywords